
【News_EN】
new order | old order


RevolKa Started joint research of a drug discovery program for rare diseases

RevolKa launched a drug discovery program for rare diseases

RevolKa completed the contract research with SEKISUI CHEMICAL CO., LTD

RevolKa Signed Master Service Agreement with Daiichi Sankyo

La Jolla Institute for Immunology and RevolKa started a Research Collaboration

Presentation movie uploaded at Antibody Engineering & Therapeutics 2023

RevolKa raises ¥150 million series A extension

SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement

Presenting at Antibody Engineering & Therapeutics
LATEST ARTICLE
ARCHIVE
- 2025/02 (1)
- 2024/11 (1)
- 2024/10 (1)
- 2024/08 (4)
- 2024/07 (4)
- 2024/05 (2)
- 2024/04 (2)
- 2024/03 (1)
- 2024/02 (4)
- 2024/01 (2)
- 2023/12 (2)
- 2023/11 (1)
CATEGORY
View allTAG